BASF ups Pronova bid
16 January 2013 Business
Pronova BioPharma specialises in omega-3 fatty acids
BASF bids €664m for omega-3 company
22 November 2012
BASF is to spend €664 million (£530 million) to buy Norwegian firm Pronova BioPharma, which specialises in omega-3 fatty acids. It has the backing of the Pronova board and shareholders representing 60% of the company, including private equity fund Herkules, which owns a 50% stake.
Pronova makes active pharmaceutical ingredients based on omega-3 fatty acids that are used to treat cardiovascular conditions. It also makes dietary supplements.
BASF says that omega-3 fatty acids represent a growing market. The company gained a significant stake in the market through its €3.1 billion purchase of german speciality chemical company Cognis in 2010. It strengthened its position in May this year when it bought UK firm Equateq.
Pronova employs 300 people and makes annual sales of about NOK1.7 billion (£180 million).
Related Content
Lean green microbe machines
30 April 2013 Feature
For its proponents, algae hold the promise of a clean source of fuel, food or drugs. Anthony King wades in
Most Read
Growing a microgarden
17 May 2013 Research
Barium carbonate crystals have been coaxed to form nano-flowers by controlling their chemical environment
3D printer churns out bionic ear
17 May 2013 Research
Seamless integration of electronics and tissue could be used with other artificial implants and synthetic organs
Most Commented
DCD in New Zealand milk
31 January 2013 Business
Dicyandiamide poses no food risk but fertiliser companies have suspended sales
3D printer churns out bionic ear
17 May 2013 Research
Seamless integration of electronics and tissue could be used with other artificial implants and synthetic organs